Search

everythinglearnresearchcommunity

for

Search:↓

Taking oral testosterone with or without dutasteride increases testosterone levels and could be an effective treatment for low testosterone.

The testes control steroid production through complex interactions involving various cells and signaling molecules.

Finasteride causes abnormal growth in male mice cells at high doses.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

Estrogens can reduce DHT production in hair follicles, but are less effective than finasteride and progesterone.

Finasteride may reduce prostate tumor cell invasion and spread.

Topical DHEA safely increases skin oil production.

Dutasteride effectively treats hair loss and prostate issues.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

The inhibitor DPP can promote hair growth.

Finasteride lowers scalp and blood DHT levels, potentially treating male-pattern baldness.

Certain finger length ratios and body hair patterns may predict side effects from birth control pills in women.

Androgens may cause hair loss by increasing TGF-beta1 from scalp cells, which inhibits hair cell growth.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

Prostaglandin D2, found in higher levels in bald scalps, stops hair growth and could be a target for treating hair loss.

Finasteride use may be linked to rare testicular tumor, but more research needed.

The new compounds may be more effective and cheaper than current treatments for conditions like baldness.

A substance called DKK-1 increases in balding areas and causes hair cells to die when exposed to DHT.

Prostate cancer risk is not linked to blood testosterone levels.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Dihydrotestosterone (DHT) worsens heart enlargement, and blocking it may help prevent heart issues.

Finasteride reduces prostate size and DHT in male mastomys but not in females.

CB-03-04 shows promise as a treatment for prostate issues due to its strong anti-androgen effects.

Dutasteride may help shrink prostate cancer tumors.